These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1970389)

  • 1. von Willebrand factor activity in primary and in scleroderma-associated Raynaud's phenomenon.
    Cuenca R; Fernadez-Cortijo J; Fonollosa V; Lima J; Simeon CP; Vilardell M; Pico M
    Lancet; 1990 May; 335(8697):1095. PubMed ID: 1970389
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon.
    Kahaleh MB; Osborn I; LeRoy EC
    Ann Intern Med; 1981 Apr; 94(4 pt 1):482-4. PubMed ID: 6782927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of soluble adhesion molecules in primary Raynaud's phenomenon and in Raynaud's phenomenon secondary to connective tissue diseases.
    Brevetti G; De Caterina M; Martone VD; Corrado S; Silvestro A; Spadaro G; Scopacasa F
    Int J Clin Lab Res; 2000; 30(2):75-81. PubMed ID: 11043500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of tissue-type plasminogen activator and von Willebrand factor in patients with Raynaud's phenomenon.
    Marasini B; Cugno M; Agostoni A
    Arthritis Rheum; 1991 Feb; 34(2):255-6. PubMed ID: 1899793
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of total-body cold exposure on plasma concentrations of von Willebrand factor, endothelin-1 and thrombomodulin in systemic lupus erythematosus patients with or without Raynaud's phenomenon.
    Matsuda J; Tsukamoto M; Gohchi K; Saitoh N; Miyajima Y; Kazama M
    Acta Haematol; 1992; 88(4):189-93. PubMed ID: 1337960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin, vasoconstriction, and endothelial damage in Raynaud's phenomenon.
    Cimminiello C; Milani M; Uberti T; Arpaia G; Perolini S; Bonfardeci G
    Lancet; 1991 Jan; 337(8733):114-5. PubMed ID: 1670699
    [No Abstract]   [Full Text] [Related]  

  • 7. [Endothelin-1 in pathogenesis of Raynaud's syndrome].
    Knapik-Kordecka M; Adamiec R; Ciosek W
    Pol Merkur Lekarski; 2001 Jun; 10(60):424-5. PubMed ID: 11503255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
    Rychlik-Golema W; Mastej K; Adamiec R
    Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of von Willebrand factor and fibrinogen plasma levels with primary Raynaud's phenomenon in male and female patients.
    Takáts AT; Shemirani AH; Zsóri KS; András C; Csiki Z
    Rheumatol Int; 2013 Apr; 33(4):1083-4. PubMed ID: 22108676
    [No Abstract]   [Full Text] [Related]  

  • 10. The associations between plasma levels of von Willebrand factor and fibrinogen with Raynaud's phenomenon in men and women.
    Fraenkel L; Tofler GH; Zhang Y; Silbershatz H; D'Agostino RB; Wilson PW; Felson DT
    Am J Med; 2000 May; 108(7):583-6. PubMed ID: 10806290
    [No Abstract]   [Full Text] [Related]  

  • 11. Persistent Raynaud's phenomenon after exposure to vinyl chloride monomer: assessment of endothelial damage.
    Fontana L; Marion MJ; Catilina P
    Clin Exp Rheumatol; 2004; 22(1):132-3. PubMed ID: 15005018
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxidant/antioxidant status in patients with Raynaud's disease.
    Biondi R; Coaccioli S; Lattanzi S; Puxeddu A; Papini M
    Clin Ter; 2008; 159(2):77-81. PubMed ID: 18463765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raynaud's phenomenon, anticentromere antibodies, and digital necrosis without sclerodactyly: an entity independent of scleroderma?
    Sachsenberg-Studer EM; Prins C; Saurat JH; Salomon D
    J Am Acad Dermatol; 2000 Oct; 43(4):631-4. PubMed ID: 11004618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis.
    Herrick AL; Illingworth K; Blann A; Hay CR; Hollis S; Jayson MI
    Ann Rheum Dis; 1996 Feb; 55(2):122-7. PubMed ID: 8712862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon.
    Lau CS; McLaren M; Mackay I; Belch JJ
    Ann Rheum Dis; 1993 Jun; 52(6):443-8. PubMed ID: 8323396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
    Gardinali M; Pozzi MR; Bernareggi M; Montani N; Allevi E; Catena L; Cugno M; Bottasso B; Stabilini R
    J Rheumatol; 2001 Apr; 28(4):786-94. PubMed ID: 11327251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiendothelial cell antibodies: useful markers of systemic sclerosis.
    Salojin KV; Le Tonquèze M; Saraux A; Nassonov EL; Dueymes M; Piette JC; Youinou PY
    Am J Med; 1997 Feb; 102(2):178-85. PubMed ID: 9217568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Raynaud's phenomenon and connective tissue diseases].
    Guilmot JL; Diot E; Lasfargues G; Boissier C
    Rev Prat; 1998 Oct; 48(15):1647-52. PubMed ID: 9814065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis.
    Fontenelle SM; Kayser C; Pucinelli ML; Andrade LE
    Rheumatology (Oxford); 2008 Jan; 47(1):80-3. PubMed ID: 18077495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased platelet function and von Willebrand factor in vibration syndrome.
    Ikehata K; Kawauchi S; Kohno F; Nishiyama M; Ide N
    Tokushima J Exp Med; 1980 Jun; 27(1-2):23-8. PubMed ID: 6968462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.